Indian stock markets are expected to react to a mix of earnings announcements, regulatory updates, commodity price movements, and corporate developments on April 20, 2026. Several large-cap and mid-cap stocks are likely to remain in focus based on confirmed disclosures and sector triggers.
Banking & Financial Stocks in Focus
ICICI Bank reported quarterly numbers above estimates. Net interest income (NII) rose 8.4% YoY, while profit increased 8.5% YoY, indicating steady operational performance.
HDFC Bank reported NII below estimates, with net interest margins (NIM) remaining under pressure. The divergence in performance between major private banks could influence sectoral sentiment.
Yes Bank posted strong Q4 and FY26 results, showing improvement across key metrics, suggesting ongoing balance sheet stabilisation.
Jio Financial Services reported a 78% YoY rise in total income, while NII increased 29% YoY, indicating strong growth momentum.
Oil & Energy Stocks Track Crude Price Surge
Oil-related stocks such as Oil and Natural Gas Corporation and Oil India Limited are expected to react after crude oil prices surged 7%, with Brent nearing $95 per barrel amid West Asia tensions.
However, higher crude prices may weigh on downstream companies, including oil marketing companies (OMCs) and paint firms due to potential margin pressure.
Hindustan Petroleum Corporation Limited is also in focus after revising its 9 mtpa refinery and petrochemical project structure, increasing its investment to ₹19,600 crore.
Cement, Infrastructure & Capital Goods
UltraTech Cement commissioned 8.7 mtpa capacity, taking its total grey cement capacity beyond 200 mtpa, reflecting ongoing expansion.
Bharat Heavy Electricals Limited reported a 19% YoY decline in FY26 order inflows, though revenue growth stood at approximately 15% YoY.
Dredging Corporation of India signed a ₹2,157 crore fuel supply MoU with Indian Oil Corporation Limited.
Titagarh Rail Systems launched the fourth diving support craft for the Indian Navy, indicating progress in defence manufacturing.
EMS Limited emerged as the lowest bidder for two UP Jal Nigam contracts worth ₹144 crore.
Pharma Stocks: US FDA Updates
Aurobindo Pharma received US FDA approval for Dextromethorphan Polistirex, a drug with a market size of $138 million.
Cipla and Lupin received US FDA Form 483 observations for their Goa and New Jersey facilities, respectively. These observations may require corrective actions but are not final compliance rulings.
Exchange, Power & Regulatory Developments
Multi Commodity Exchange of India received SEBI approval under SECC regulations to invest in a proposed coal exchange company.
Indian Energy Exchange is in focus after the regulator released a draft framework on power market norms, including provisions for market coupling.
Media, Hospitality & Auto-Linked Stocks
Zee Entertainment Enterprises approved an investment of ₹116 crore in Phantom Digital Effects.
Lemon Tree Hotels announced the signing of a new hotel in Garudeshwar, indicating continued expansion in the hospitality segment.
Popular Vehicles and Services reported a 69% YoY increase in Q4 revenue, with new vehicle volumes rising 44% YoY.
TVS Supply Chain Solutions settled a debt dispute with ZTE Corporation and withdrew its plea in NCLAT.
Other Key Corporate Developments
OneSource Specialty Pharma received renewal of EU-GMP certification for its Unit II facility in Bengaluru.
Bharat Wire Ropes saw approximately 5% stake acquisition by the Lloyd Group via block deals.
Shyam Metalics and Energy faced enforcement action, with the ED provisionally attaching ₹160 crore of investments linked to alleged illegal coal mining.
Hindustan Copper Limited reported the death of a contractual worker at its Rajasthan unit.
Mastek reported a slight decline in margins to 16.10% from 16.80% YoY, with profit down 2% QoQ.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.